Des Plaines, Illinois — According to state and local development sources, Vetter Pharma International plans to invest $285 Million to build out 160,000 square feet of new space in Des Plaines. The company plans to occupy the new space at 10 W Algonquin Rd in Des Plaines, on or about August 1, 2029. According to the company website Vetter is a leading Contract Development and Manufacturing Organization (CDMO) with headquarters in Ravensburg, Germany, and production facilities in Germany, Austria, and the US. As a global player, the independent pharmaceutical service provider is also present in the Asia-Pacific markets of Japan, China, South Korea and Singapore with sales locations. Around the world, small and large renowned pharma and biotech companies rely on the decades of experience, high quality, modern technologies, reliability, and commitment of its more than 7,000 employees. In close partnership with its customers, the Vetter team supplies patients all over the world with medicines, many of which are vital. The CDMO provides support from drug product development through clinical and commercial filling to a wide range of assembly and packaging services for vials, syringes, and cartridges. With innovative solutions, Vetter develops prefilled drug-delivery systems together with its customers to continuously improve patient safety, comfort, and compliance. The company is an industry pioneer in sustainability and a socially and ethically responsible corporate citizen.

To learn more about Vetter Pharma International, visit https://www.vetter-pharma.com/

Company Contact:
Henryk Badack, Managing Director
847-581-6888

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.